TREA

90779841 - ABQURE

Follow

Information

  • Trademark
  • 90779841
  • Serial Number
    90779841
  • Registration Number
    7102820
  • Filing Date
    June 17, 2021
    3 years ago
  • Registration Date
    July 11, 2023
    a year ago
  • Transaction Date
    July 11, 2023
    a year ago
  • Status Date
    July 11, 2023
    a year ago
  • Published for Opposition Date
    February 14, 2023
    a year ago
  • Location Date
    July 11, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHADAB, SETH WILLIG
  • Attorney Docket Number
    115710.00641
    Attorney Name
    Julianne Abelman
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ABQURE
Case File Statements
  • GS0051: Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases
  • GS0441: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
  • GS0421: Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Case File Event Statements
  • 7/11/2023 - a year ago
    34 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/11/2023 - a year ago
    33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/8/2023 - a year ago
    32 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 4/14/2023 - a year ago
    31 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 6/1/2023 - a year ago
    30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 4/14/2023 - a year ago
    29 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 4/11/2023 - a year ago
    28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/14/2023 - a year ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/14/2023 - a year ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/25/2023 - a year ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/12/2023 - a year ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/9/2023 - a year ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/9/2023 - a year ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/9/2023 - a year ago
    21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/14/2022 - 2 years ago
    20 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/14/2022 - 2 years ago
    19 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/14/2022 - 2 years ago
    18 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/3/2022 - 2 years ago
    17 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 9/20/2022 - 2 years ago
    16 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 9/7/2022 - 2 years ago
    15 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 9/2/2022 - 2 years ago
    14 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 8/30/2022 - 2 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/10/2022 - 2 years ago
    12 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 7/26/2022 - 2 years ago
    11 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 7/20/2022 - 2 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/20/2022 - 2 years ago
    9 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 7/20/2022 - 2 years ago
    8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/20/2022 - 2 years ago
    7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/10/2022 - 2 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 2/10/2022 - 2 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/10/2022 - 2 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/8/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/3/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/21/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP